© 2000 by European Society of Cardiology
Copyright © 2000, European Society of Cardiology
Effect of chronic AT1 receptor blockade on cardiac Smad overexpression in hereditary cardiomyopathic hamsters
Laboratory of Molecular Cardiology, Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, Faculty of Medicine, University of Manitoba, 351 Tache Avenue, Winnipeg, Manitoba, Canada R2H 2A6
* Corresponding author. Tel.: +1-204-235-3419; fax: +1-204-233-6723 iand{at}sbrc.umanitoba.ca
Objective: As the pharmacological suppression of angiotensin has been associated with cardioprotective effects in cardiomyopathy, our primary aim was to determine whether the expression of Smad protein components of the cardiac TGF-β signaling cascade is modulated by chronic AT1 receptor blockade. Furthermore, we examined the relationship between cardiac Smad protein expression and altered collagen turnover in the cardiomyopathic heart. Methods: Male UM-X7.1 cardiomyopathic (CMP) Syrian hamsters at early (65 days) and late (200 days) stages of cardiomyopathy were subjected to 4 week losartan (15 mg/kg/day) treatment. Expression of left ventricular (LV) receptor-activated (Smad 2) and common-mediator (Smad 4) Smads from control (F1-β strain) hamsters, non-treated cardiomyopathic (CMP), and losartan-treated CMP animals was assessed. Collagen turnover, including fibrillar collagen synthesis/accretion and cardiac MMP activity was assessed. Results: Elevated mRNA abundance of fibrillar collagens and ANF were present in cardiomyopathic hearts and these trends were normalized in the early stage losartan-treated group. 4-Hydroxyproline and zymographic assays confirmed fibrosis and elevated MMP-1 and -2 activities in CMP hearts. Losartan treatment was associated with a modest reduction of cardiac 4-hydroxyproline concentration, and a significant reduction of both MMP-1 and MMP-2 activities. While TGF-β1 mRNAs were elevated in both CMP groups vs. controls, total TGF-β protein content was not different in CMP vs. controls. In LV preparations containing nuclear extract, elevated Smad 2 and Smad 4 protein expression was noted in cardiomyopathic hearts vs. controls. Losartan treatment of late-stage CMP hamsters was associated with a significant reduction in Smad 2 and a modest reduction of Smad 4 protein expression vs. untreated CMP samples. Conclusions: Altered cardiac Smad expression, present in both early and late stage cardiomyopathy, is positively correlated with the occurrence of cardiac fibrosis and elevated collagen turnover in failing CMP hearts. Four week AT1 blockade is associated with normalized expression of cardiac Smad 2 proteins, and these changes occur in parallel with some aspects of collagen turnover in failing cardiomyopathic hearts.
KEYWORDS Angiotensin; Fibrosis; Cardiomyopathy; Heart failure
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. M. Abarbanell, A. C. Coffey, J. W. Fehrenbacher, D. J. Beckman, J. L. Herrmann, B. Weil, and D. R. Meldrum Proinflammatory cytokine effects on mesenchymal stem cell therapy for the ischemic heart. Ann. Thorac. Surg., September 1, 2009; 88(3): 1036 - 1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. De Backer The expanding cardiovascular phenotype of Marfan syndrome Eur J Echocardiogr, March 1, 2009; 10(2): 213 - 215. [Full Text] [PDF] |
||||
![]() |
M. Hoberg, M. Rudert, T. Pap, G. Klein, S. Gay, and W. K Aicher Attachment to laminin-111 facilitates transforming growth factor {beta}-induced expression of matrix metalloproteinase-3 in synovial fibroblasts Ann Rheum Dis, April 1, 2007; 66(4): 446 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liu, S. Q. Sun, A. Hassid, and R. S. Ostrom cAMP Inhibits Transforming Growth Factor-beta-Stimulated Collagen Synthesis via Inhibition of Extracellular Signal-Regulated Kinase 1/2 and Smad Signaling in Cardiac Fibroblasts Mol. Pharmacol., December 1, 2006; 70(6): 1992 - 2003. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vanhoutte, M. Schellings, Y. Pinto, and S. Heymans Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: A temporal and spatial window Cardiovasc Res, February 15, 2006; 69(3): 604 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Euler-Taimor and J. Heger The complex pattern of SMAD signaling in the cardiovascular system Cardiovasc Res, January 1, 2006; 69(1): 15 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, N. Xu, X. Feng, N. Hou, J. Zhang, X. Cheng, Y. Chen, Y. Zhang, and X. Yang Targeted Disruption of Smad4 in Cardiomyocytes Results in Cardiac Hypertrophy and Heart Failure Circ. Res., October 14, 2005; 97(8): 821 - 828. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rosenkranz TGF-{beta}1 and angiotensin networking in cardiac remodeling Cardiovasc Res, August 15, 2004; 63(3): 423 - 432. [Abstract] [Full Text] [PDF] |
||||





